Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Atherosclerosis. 2017 Sep 18;266:16–23. doi: 10.1016/j.atherosclerosis.2017.09.019

Figure 2.

Figure 2

Cross sectional association of hs-CRP with general health status 30 days after AMI (hs-CRP ≥2.0 mg/dL compared with <2 mg/dL).

Data shown as change in the health status measures and 95% confidence interval. Full model is adjusted for age, gender, race, body mass index, socioeconomic status, prior smoking and alcohol use, history of AMI, peripheral arterial disease, percutaneous coronary intervention, atrial fibrillation, diabetes, hypertension, dyslipidemia, and lung disease, use of lipid lowering medications at discharge, and baseline health status

AMI, acute myocardial infarction; EQ-5D VAS, Euro Quality of Life Visual Analog Scale; hs-CRP, high-sensitivity C-reactive protein; SF-12 MCS, The Medical Outcome Study Short From-12 mental component scale; SF-12 PCS, The Medical Outcome Study Short From-12 physical component scale.